Tirzepatide · SURMOUNT-1
20.9% average body-weight reduction at 72 weeks. Highest-dose group (15 mg); published phase 3 trial.
SURMOUNT-1 publication · PubMed💳 CREDIT / DEBIT CARD PAYMENTS ARE TEMPORARILY DISABLED due to a technical issue. You can still pay with Interac e-Transfer, PayPal or Bitcoin. We'll let you know as soon as cards are back.

FirstLabs PH · Research & resources
A little more clarity.
Explore research, check your measurements,
and get your questions answered.
General information only · No personal-use or dosing advice
Clinical study perspective
See how study-average weight changes translate to your starting weight.
Equivalent weight change at the study average
20.9% average reduction · SURMOUNT-1 · 72 weeks
Highest-dose study group
This is an illustration based on clinical-trial averages, not a prediction of your results. These studies involved adults with obesity or overweight without diabetes, alongside lifestyle support. Individual results vary. These were separate trials, not a direct comparison. Retatrutide remains investigational.
FirstLabs products were not used in these trials. Our products are for laboratory research only, not human consumption.
Adds one TIRZEPATIDE 20MG research vial (C$100.00) and opens checkout. The vial size is a catalogue choice, not a dosing recommendation — see all sizes. Research use only.
Sample reports do not establish current-stock traceability. Availability is checked again at checkout.
20.9% average body-weight reduction at 72 weeks. Highest-dose group (15 mg); published phase 3 trial.
SURMOUNT-1 publication · PubMed25.0% average body-weight reduction at 80 weeks. Highest-dose group (12 mg); treatment-regimen (intention-to-treat) analysis from the published phase 3 trial. The Lilly release’s 28.3% headline uses a different analysis, not the 25.0% used here.
TRIUMPH-1 results · Lilly news releasePublished 25.0% analysis · PubMedDifferent trial populations and analyses limit comparisons. Trial averages do not establish individual outcomes or the safety, quality or suitability of any FirstLabs catalogue product.
01 / YOUR MEASUREMENTS
Enter your height and weight to see your Body Mass Index and whether it falls in the underweight, healthy, overweight or obese range. This is a general screening tool only — it doesn't account for muscle, age or body composition, and it isn't medical advice.
— BMI
Your result appears here
Another general screening measure: measure your waist at the belly button and compare it to your height. A common rule of thumb is to keep your waist under half your height. General information only — not medical advice.
— RATIO
Your result appears here
Lab-prep math for research solutions: enter the total milligrams in a vial and how much bacteriostatic water you add, and it shows the resulting concentration and the syringe math. Purely informational — for laboratory research only, not dosing or personal-use guidance.
— mg/mL
Your concentration appears here
02 / EXPLORE & ASK
Research & order questions · Demo
Demo answers are pre-written. Products are strictly for laboratory research, not human consumption. For personal health questions, consult a licensed healthcare provider.
Prefer a human? Leave your email and your question — we reply personally, usually within a day.
Join the FirstLabsPH partner program — built for researchers, educators, and creators who recommend independently verified peptides. Real-time dashboard, lifetime referral attribution, and on-time payouts.